Healthcare provider profile · identity verified

Dee Althouse, MD

Internal Medicine · HAVRE, MT · NPI 1578776118

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	346	68
Levothyroxine Sodium	Levothyroxine Sodium	246	42
Gabapentin	Gabapentin	236	32
Lisinopril	Lisinopril	221	50
Omeprazole	Omeprazole	204	42
Losartan Potassium	Losartan Potassium	181	40
Amlodipine Besylate	Amlodipine Besylate	179	39
Pantoprazole Sodium	Pantoprazole Sodium	134	20
Metoprolol Succinate	Metoprolol Succinate	125	27
Rosuvastatin Calcium	Rosuvastatin Calcium	125	21
Trazodone Hcl	Trazodone Hcl	113	18
Sertraline Hcl	Sertraline Hcl	108	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	107	12
Metformin Hcl	Metformin Hcl	102	19
Duloxetine Hcl	Duloxetine Hcl	99	12
Furosemide	Furosemide	92	22
Jardiance	Empagliflozin	88	19
Simvastatin	Simvastatin	88	16
Ozempic	Semaglutide	87	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	83	19
Metformin Hcl Er	Metformin Hcl	82	17
Hydrochlorothiazide	Hydrochlorothiazide	77	20
Pregabalin	Pregabalin	74	13
Oxycodone Hcl	Oxycodone Hcl	73	suppressed
Famotidine	Famotidine	70	11
Potassium Chloride	Potassium Chloride	69	16
Albuterol Sulfate Hfa	Albuterol Sulfate	68	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	65	11
Tamsulosin Hcl	Tamsulosin Hcl	62	12
Irbesartan	Irbesartan	57	suppressed
Carvedilol	Carvedilol	56	suppressed
Eliquis	Apixaban	56	11
Amitriptyline Hcl	Amitriptyline Hcl	52	suppressed
Celecoxib	Celecoxib	51	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	49	suppressed
Spironolactone	Spironolactone	48	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	47	suppressed
Ropinirole Hcl	Ropinirole Hcl	44	suppressed
Ondansetron Odt	Ondansetron	43	suppressed
Allopurinol	Allopurinol	42	suppressed
Baclofen	Baclofen	42	suppressed
Clopidogrel	Clopidogrel Bisulfate	42	suppressed
Januvia	Sitagliptin Phosphate	40	suppressed
Meloxicam	Meloxicam	37	suppressed
Topiramate	Topiramate	37	suppressed
Tramadol Hcl	Tramadol Hcl	37	suppressed
Xarelto	Rivaroxaban	37	suppressed
Promethazine Hcl	Promethazine Hcl	36	suppressed
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Ventolin Hfa	Albuterol Sulfate	35	14
Diazepam	Diazepam	34	suppressed
Novolog Flexpen	Insulin Aspart	34	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	30	suppressed
Clonazepam	Clonazepam	30	suppressed
Diclofenac Sodium	Diclofenac Sodium	30	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	12
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Trulicity	Dulaglutide	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Victoza 3-Pak	Liraglutide	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	24	suppressed
Calcitriol	Calcitriol	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Diltiazem Hcl	Diltiazem Hcl	22	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Testosterone Cypionate	Testosterone Cypionate	22	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Estradiol	Estradiol	20	suppressed
Finasteride	Finasteride	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Varenicline Tartrate	Varenicline Tartrate	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Naproxen	Naproxen	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	12
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Levofloxacin	Levofloxacin	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Atenolol	Atenolol	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Liothyronine Sodium	Liothyronine Sodium	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Oxcarbazepine	Oxcarbazepine	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Prednisone	Prednisone	14	11
Amoxicillin	Amoxicillin	13	11
Chlorthalidone	Chlorthalidone	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Nurtec Odt	Rimegepant Sulfate	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Gemtesa	Vibegron	12	suppressed
Glyburide	Glyburide	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Pulmicort Flexhaler	Budesonide	11	suppressed
Wegovy	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error